Device Trial Radar · NCT05985304
Clinical Trial of a Hydrophilic EMV Toric Lens RAO210T in the Correction of Aphakia and Corneal Astigmatism
Last checked: Nov 20, 2026Latest source record: Jan 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
274
Actual
Start
Aug 10, 2023
Primary completion
Oct 23, 2024
Study completion Oct 23, 2024
Sponsor
- Lead sponsor
- Rayner Intraocular Lenses LimitedNot on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 14, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objectives of the clinical investigation are to determine the safety and performance of the RayOne EMV Toric (Model RAO210T) following unilateral implantation and approximately 6 months (120 to 180 days) of post-operative assessment, as a randomized comparison to aspheric monofocal control for low cylinder (1.50 D). This patient population with cataracts and low corneal cylinder (+1.00 to +1.50 D) will have the natural crystalline lens removed and replaced with an intraocular lens in the capsular bag.
Conditions
- Cataract
- Corneal Astigmatism
Interventions
RayOne EMV Toric IOLDevice
Implantation of intraocular lens.
RayOne Monofocal IOLDevice
Implantation of intraocular lens.
Cataract SurgeryProcedure
Removal of natural crystalline lens due to cataracts
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Magnitude of Residual Manifest CylinderTime frame: 120 to 180 days post-operatively
8 more outcomes with a free account
Locations
9 sites in 1 country. Site status is shown where the registry gives one.
Vold Vision
Fayetteville, Arkansas
8 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.